US Stock MarketDetailed Quotes
TTOO T2 Biosystems
- 0.5723
- +0.0744+14.94%
Close Nov 29 13:00 ET
- 0.5829
- +0.0106+1.85%
Post 17:02 ET
12.04MMarket Cap-19076P/E (TTM)
0.5800High0.5030Low1.98MVolume0.5190Open0.4979Pre Close1.10MTurnover24.87%Turnover RatioLossP/E (Static)21.04MShares8.379952wk High-1.03P/B4.55MFloat Cap0.415652wk Low--Dividend TTM7.95MShs Float122500.0000Historical High--Div YieldTTM15.47%Amplitude0.4156Historical Low0.5570Avg Price1Lot Size
T2 Biosystems Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 53.32%-6.25M | 25.40%-9.24M | 9.71%-11.68M | 4.92%-48.14M | 8.84%-9.42M | 15.78%-13.39M | -24.42%-12.39M | 10.39%-12.94M | -30.24%-50.63M | -4.95%-10.33M |
| Net income from continuing operations | 34.41%-10.12M | -41.22%-8.96M | 24.66%-13.53M | 19.23%-50.08M | -2.39%-10.34M | 11.22%-15.43M | 64.81%-6.35M | -8.91%-17.97M | -25.92%-62M | 16.84%-10.1M |
| Operating gains losses | -153.35%-398K | 87.38%-1.04M | -96.15%80K | -754.04%-5.42M | 96.48%-31K | 2,160.61%746K | ---8.21M | --2.08M | 180.96%829K | ---881K |
| Depreciation and amortization | -77.48%59K | -76.78%62K | -75.00%64K | -17.96%859K | -70.98%74K | 0.77%262K | 8.54%267K | -10.49%256K | -58.75%1.05M | -54.14%255K |
| Other non cash items | -17.34%515K | -53.74%396K | -53.89%705K | 9.74%3.68M | -19.24%676K | -28.31%623K | 5.16%856K | 82.68%1.53M | -14.67%3.36M | -17.70%837K |
| Change In working capital | 216.27%3.47M | -32.61%93K | 11.49%-593K | -703.58%-4.04M | 67.85%-523K | -181.26%-2.99M | -96.38%138K | 58.67%-670K | 76.83%-503K | -118.68%-1.63M |
| -Change in receivables | -450.48%-736K | 1,219.23%291K | -120.00%-168K | -74.99%743K | 51.97%-281K | -81.63%210K | -101.59%-26K | 8.67%840K | 8,588.57%2.97M | 35.86%-585K |
| -Change in inventory | 914.55%1.34M | -186.78%-499K | 115.70%149K | 21.60%-744K | -52.99%-205K | -115.46%-165K | 265.23%575K | 38.14%-949K | 51.08%-949K | -436.00%-134K |
| -Change in prepaid assets | 139.98%421K | 87.61%818K | 13.04%156K | -216.77%-550K | -161.74%-71K | -196.62%-1.05M | -80.06%436K | 109.35%138K | 200.86%471K | -48.89%115K |
| -Change in payables and accrued expense | 277.25%2.88M | 75.32%-153K | 16.14%-317K | -70.27%-2.22M | 169.22%398K | 36.62%-1.62M | -180.10%-620K | -135.83%-378K | -185.29%-1.31M | -248.20%-575K |
| -Change in other current liabilities | -19.77%-412K | -19.52%-398K | -19.69%-383K | 1.24%-1.35M | 29.14%-355K | -15.05%-344K | -14.43%-333K | -15.11%-320K | -18.94%-1.37M | -65.35%-501K |
| -Change in other working capital | -46.15%-19K | -67.92%34K | -2,900.00%-30K | 125.78%83K | -116.98%-9K | 77.97%-13K | 168.39%106K | 99.38%-1K | -198.15%-322K | 145.30%53K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 53.32%-6.25M | 25.40%-9.24M | 9.71%-11.68M | 4.92%-48.14M | 8.84%-9.42M | 15.78%-13.39M | -24.42%-12.39M | 10.39%-12.94M | -30.24%-50.63M | -4.95%-10.33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | -101.99%-192K | 27.78%-26K | 89.68%-13K | -100.34%-33K | -313.79%-120K | -61.04%9.66M | -100.37%-36K |
| Net PPE purchase and sale | --0 | --0 | --0 | 43.36%-192K | 27.78%-26K | 89.68%-13K | 77.70%-33K | -313.79%-120K | 26.30%-339K | 81.91%-36K |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -60.41%10M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | -101.99%-192K | 27.78%-26K | 89.68%-13K | -100.34%-33K | -313.79%-120K | -61.04%9.66M | -100.37%-36K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -81.11%4.09M | -60.41%7.28M | -81.41%2.2M | 81.35%52.69M | 8.56%812K | -6.65%21.64M | 368.94%18.39M | 885.69%11.85M | 41.49%29.05M | 212.97%748K |
| Net common stock issuance | -81.16%4.09M | -60.46%7.27M | -81.41%2.2M | 80.82%52.73M | -24.43%795K | -5.16%21.7M | 384.58%18.39M | 727.37%11.85M | 46.04%29.16M | --1.05M |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---30K | ---330K |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | -88.48%19K | -34.62%17K | --0 | ---- | ---- | -70.90%165K | -89.12%26K |
| Net other financing activities | --0 | --0 | ---1K | 74.49%-62K | --0 | ---- | ---- | ---- | ---243K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -81.11%4.09M | -60.41%7.28M | -81.41%2.2M | 81.35%52.69M | 8.56%812K | -6.65%21.64M | 368.94%18.39M | 885.69%11.85M | 41.49%29.05M | 212.97%748K |
| Net cash flow | ||||||||||
| Beginning cash position | -71.16%4.8M | -36.64%6.76M | 36.70%16.24M | -50.08%11.88M | 15.69%24.87M | 15.98%16.64M | 1.33%10.67M | -50.08%11.88M | 37.20%23.8M | -8.90%21.5M |
| Current changes in cash | -126.27%-2.16M | -132.88%-1.96M | -682.26%-9.48M | 136.59%4.36M | 10.26%-8.63M | 15.11%8.24M | 56.41%5.97M | 90.87%-1.21M | -284.69%-11.92M | -4,957.07%-9.62M |
| End cash Position | -89.41%2.63M | -71.16%4.8M | -36.64%6.76M | 36.70%16.24M | 36.70%16.24M | 15.69%24.87M | 15.98%16.64M | 1.33%10.67M | -50.08%11.88M | -50.08%11.88M |
| Free cash flow | 53.36%-6.25M | 25.60%-9.24M | 10.54%-11.68M | 5.18%-48.33M | 8.90%-9.44M | 16.36%-13.41M | -22.92%-12.42M | 9.74%-13.06M | -29.58%-50.97M | -3.23%-10.37M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
